Please provide your email address to receive an email when new articles are posted on . Brixadi is the first long-acting buprenorphine injectable that is available in weekly and monthly doses.

Single-use and reusable needle-free injection devices will be designed for precise self-administration and home use. PharmaJet injector pens are intended for needle-free subcutaneous delivery of a ...

Credit: Getty Images. Endo’s product is the only ready-to-use formulation of bivalirudin currently on the market. Endo International has announced the launch of Bivalirudin Injection in a ready-to-use ...

The demographic profile of the respondents was similar to ACNM membership in age and years of experience. The distribution of birth settings in the sample was the same as ACNM members for hospital ...